We work closely with leading pharma, biotech, and diagnostic companies during every phase of development, augmenting their systems and processes with the unique InterVenn platform.
Our approaches can be complementary/orthogonal (multi-omic), supplementary (boosting assay performance) or "you've-tried-everything-and-nothing-seems-to-work" (exclusive glyco-only analysis).
Glyco-as-a-Complement (GaaC) to DNA / RNA based assays
Enabling better therapy choice and response monitoring
Discovering new novel glycosylated targets
Pharma, Biotech and Diagnostic Partner RUO Services
(Peak Integration Program)
By continuing to browse this site, you agree to our privacy policy and use of cookies.